Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation

Description

The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.

Resources

Name Format Description Link
Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation HTML https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/draft-management-rolling-reviews-submissions/performance-targets-standards-cancellation.html
Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation HTML https://www.canada.ca/fr/sante-canada/programmes/consultation-projet-reglementation-souple-lignes-directrices-homologation-medicaments-instruments-medicaux/ebauche-gestion-examens-continu-presentations/objectifs-normes-rendement-annulation.html

Tags

Topics

Categories